Phathom Pharmaceuticals (PHAT) Receivables - Other (2018)
Phathom Pharmaceuticals (PHAT) posted quarterly Receivables - Other of $19000.0 for Q4 2018.
Phathom Pharmaceuticals (PHAT) Receivables - Other (2018) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has reported Receivables - Other for 1 consecutive years, with $19000.0 the latest figure, recorded in Q4 2018.
- In Q4 2018, Receivables - Other changed N/A year-over-year to $19000.0; the TTM figure through Dec 2018 stood at $19000.0 (changed N/A YoY), while the FY2018 annual figure was $19000.0, changed N/A from the prior year.
- Receivables - Other steadied at $19000.0 in Q4 2018 per PHAT's latest filing.
- Across five years, Receivables - Other topped out at $19000.0 in Q4 2018 and bottomed at $19000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Phathom Pharmaceuticals | 767.07 Mn | 581.73 Mn | 59.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 19,000.00 |
| Dec 31, 2018 | 19,000.00 |